|
SPOP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.29709609509155E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.78739997749966E-09 |
| Normal-vs-Stage2 |
1.52239999999804E-05 |
| Normal-vs-Stage3 |
7.4185102505453E-13 |
| Normal-vs-Stage4 |
1.71740399679265E-12 |
| Stage1-vs-Stage2 |
9.458000E-01 |
| Stage1-vs-Stage3 |
7.239400E-03 |
| Stage1-vs-Stage4 |
9.378600E-04 |
| Stage2-vs-Stage3 |
8.770000E-02 |
| Stage2-vs-Stage4 |
2.955600E-02 |
| Stage3-vs-Stage4 |
4.594600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12163620005867E-13 |
| Normal-vs-AfricanAmerican |
6.45309999999233E-05 |
| Normal-vs-Asian |
2.89539999998034E-06 |
| Caucasian-vs-AfricanAmerican |
5.045200E-01 |
| Caucasian-vs-Asian |
1.574570E-01 |
| AfricanAmerican-vs-Asian |
7.483600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.47308856621476E-13 |
| Normal-vs-Female |
1.20049525875743E-11 |
| Male-vs-Female |
1.705230E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.86980000558424E-09 |
| Normal-vs-Age(41-60Yrs) |
1.06940012400969E-11 |
| Normal-vs-Age(61-80Yrs) |
5.86231063692821E-12 |
| Normal-vs-Age(81-100Yrs) |
1.5994500000005E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.517000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.973500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.453440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.389200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.021400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.269000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.206800E-04 |
| Classical-VS-Follicular |
6.557600E-01 |
| Classical-VS-Other |
7.824600E-01 |
| Classical-VS-Normal |
2.90849566653151E-11 |
| Tall-VS-Follicular |
1.818350E-03 |
| Tall-VS-Other |
4.240300E-02 |
| Tall-VS-Normal |
3.14137604817688E-12 |
| Follicular-VS-Other |
9.425400E-01 |
| Follicular-VS-Normal |
7.3566000002856E-07 |
| Other-VS-Normal |
1.293990E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18890008948824E-10 |
| Normal-vs-N1 |
1.00599999997009E-07 |
| N0-vs-N1 |
3.197000E-01 |
|
|
